MedPath

Effect of atropine vs. ondansetron in preventing nausea and vomiting

Phase 3
Recruiting
Conditions
ausea and vomiting.
Nausea and vomiting
Registration Number
IRCT20160825029520N4
Lead Sponsor
eyshabour University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
142
Inclusion Criteria

Age: 18-45 years old
Elective surgery
Not history of severe nausea and vomiting during pregnancy
Complete NPO time
Not taking anti-nausea medication before surgery

Exclusion Criteria

Heart rate less than 50 or more than 100 during operation
History of allergy to the drug that used in this study
History of digestive diseases
Failed Spinal Anesthesia
Bleeding more than 500 cc during surgery
Prolonged QT interval

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of Nausea and Vomiting. Timepoint: Before spinal/ after spinal/ before surgery/ after the umbilical cord clamp/ after surgery/ entering the recovery/ leaving the recovery. Method of measurement: Bellville Nausea and Vomiting scoring scale.
Secondary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: Before spinal/ after spinal/ before surgery/ after the umbilical cord clamp/ after surgery/ entering the recovery/ leaving the recovery. Method of measurement: Anesthesia monitoring.;Heart rate. Timepoint: Before spinal/ after spinal/ before surgery/ after the umbilical cord clamp/ after surgery/ entering the recovery/ leaving the recovery. Method of measurement: Anesthesia monitoring.;Temperature. Timepoint: Before spinal/ after spinal/ before surgery/ after the umbilical cord clamp/ after surgery/ entering the recovery/ leaving the recovery. Method of measurement: Tympanic membrane thermometers.
© Copyright 2025. All Rights Reserved by MedPath